FIELD: anesthesiology in open-heart operation. SUBSTANCE: invention, in particular, relates to protection of brain against anoxia caused by occlusion of main vessels during surgical corrections of congenital heart diseases under conditions of profound hypothermic protection. For that, 5 min before blood circulation stop, Ca(II) antagonist isoptin dose 5-10 mcg/kg is administered intravenously. EFFECT: increased antianoxic brain protection due to pharmacologically affecting cell membranes. 2 ex
Authors
Dates
2000-01-27—Published
1996-07-22—Filed